Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Clathrate compound containing ginsenoside Rg2 and method of preparing the same

A technology of ginsenosides and inclusion compounds, which is applied to medical preparations containing active ingredients, non-active ingredients of polymer compounds, and pharmaceutical formulations, etc. It can solve problems such as poor solubility and difficulty in preparing injections

Inactive Publication Date: 2008-03-12
GUANGZHOU TIANAN MEDICAL TECH
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have shown that the compound has two isomers of ginsenoside C-20 (S) and C-20 (R), but the compound has poor solubility in water and is difficult to prepare injections

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Clathrate compound containing ginsenoside Rg2 and method of preparing the same
  • Clathrate compound containing ginsenoside Rg2 and method of preparing the same
  • Clathrate compound containing ginsenoside Rg2 and method of preparing the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0166] Embodiment 1: Get ginsenoside Rg 2 15kg of extract, 50kg of hydroxypropyl-β-cyclodextrin, made into capsules according to conventional technology, 0.45g per capsule.

Embodiment 2

[0167] Embodiment 2: Get ginsenoside Rg 2 Extract 11kg, hydroxypropyl-β-cyclodextrin 62kg, made into tablets according to the conventional process, each tablet 0.45g.

Embodiment 3

[0168] Embodiment 3: Get ginsenoside Rg 2 Extract 18kg, hydroxypropyl-β-cyclodextrin 46kg, make oral solution according to conventional technology, each 10ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses an inclusion complex containing the panaxsaponin Rg2 and the preparation method. The inclusion complex of the invention consists of the panaxsaponin Rg2 and the hydroxypropyl-Beta-cyclodextrin. The preparation method of the present invention is as following. The hydroxypropyl-Beta-cyclodextrin water solution is prepared; the hydroxypropyl-Beta-cyclodextrin solution is kept in the water bath; the extraction powder of the panaxsaponin Rg2 or the extraction of the liquid-typed Rg2 dissoluted by the solvent is added before mixing and complex; therefore the liquid inclusion complex is obtained and the inclusion complex after drying. The inclusion complex of the present invention has functions of increasing the heart perfusion and the blood flow, expanding the diameter of the vein and the artery, improving the microcirculation disturbance, improving the myocardial ischemia and anti-thrombosis effect. The present invention can significantly reduce the acute toxicity of the panaxsaponin Rg2.

Description

technical field [0001] The invention relates to a drug inclusion compound and its quality control method, in particular to a compound containing ginsenoside Rg 2 clathrate and its quality control method. Background technique [0002] There are many kinds of ginsenosides in ginseng, and there are more than 30 kinds of ingredients that have been clearly identified, among which ginsenoside Rg 2 (Ginsegnoside Rg 2 ) is a known compound that was isolated in the early years. Before the 1990s, the medical use of this compound was not clear, so it was not developed and applied. Studies have shown that the compound has two isomers of ginsenoside C-20(S) and C-20(R), but the compound has poor solubility in water and is difficult to prepare injections. [0003] The inventor applied for "Ginsenoside Rg" in 2000 2 Invention patent (Chinese patent ZL01102117.9) for the application in the preparation of drugs for cardiovascular and cerebrovascular diseases, followed by the application...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K9/19A61K31/704A61K47/40A61P9/10A61P7/02A61P9/00
Inventor 李浩周基清
Owner GUANGZHOU TIANAN MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com